| Q1 2022 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | (EXPECTED)2022-04-28 | ||||||
| REV | |||||||
| Q4 2021 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | 1.520 | (EXPECTED) 2022-02-03 | |||||
| REV | 13.160B | ||||||
| Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
|---|
You can purchase shares of Merck & Co (NYSE: MRK) through any online brokerage.
Other companies in Merck & Co’s space includes: Novo Nordisk (NYSE:NVO), Johnson & Johnson (NYSE:JNJ), Novartis (NYSE:NVS), Roivant Sciences (NASDAQ:ROIV) and Pfizer (NYSE:PFE).
The latest price target for Merck & Co (NYSE: MRK) was reported by JP Morgan on January 28, 2022. The analyst firm set a price target for 95.00 expecting MRK to rise to within 12 months (a possible 17.37% upside). 23 analyst firms have reported ratings in the last year.
The stock price for Merck & Co (NYSE: MRK) is $80.94 last updated Fri Jan 28 2022 20:59:59 GMT+0000 (Coordinated Universal Time).
The next Merck & Co (MRK) dividend date is projected to be 2022-03-14.
Merck & Co’s $Q1 earnings are confirmed for after-market on April 28, 2022.
There is no upcoming split for Merck & Co.
Merck & Co is in the Health Care sector and Pharmaceuticals industry. They are listed on the NYSE.